|Table of Contents|

Progress in the relationship between long non-coding RNA CCAT2 and digestive system tumors

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2019 03
Page:
534-536
Research Field:
Publishing date:

Info

Title:
Progress in the relationship between long non-coding RNA CCAT2 and digestive system tumors
Author(s):
Lu ShounanJiang XingmingSu ZhileiFu WenCui ZhankunTai Sheng
Department of Hepatopancreatobiliary Surgery,the Second Affiliated Hospital of Harbin Medical University,Heilongjiang Harbin 150086,China.
Keywords:
lncRNACCAT2digestive system tumors
PACS:
R735
DOI:
10.3969/j.issn.1672-4992.2019.03.043
Abstract:
lncRNA CCAT2 is a novel lncRNA discovered in recent years,which was first identified from microsatellite stable colorectal cancer.Afterwards,it has been found and played an important role in gastric cancer,cholangiocarcinoma,hepatocellular carcinoma,and pancreatic cancer.It can induce tumor growth,metastasis and chromosomal instability and is considered to be an oncogenic lncRNA.CCAT2 can promote tumor growth and metastasis by interacting with miRNA or proteins such as E-cadherin,and plays an important role in digestive system tumors,providing new ideas for the treatment of tumors.

References:

[1]Consortium EP,Birney E,Stamatoyannopoulos JA,et al.Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project[J].Nature,2007,447(7146):799-816.
[2]Cox AD,Fesik SW,Kimmelman AC,et al.Drugging the undruggable RAS:Mission possible[J]?Nature Reviews Drug Discovery,2014,13(11):828-851.
[3]Gómezmaldonado L,Tiana M,Roche O,et al.EFNA3 long non-coding RNAs induced by hypoxia promote metastatic dissemination[J].Oncogene,2014,34(20):2609-2620.
[4]Spizzo R,Almeida MI,Colombatti A,et al.Long non-coding RNAs and cancer:A new frontier of translational research[J].Oncogene,2012,31(43):4577-4587.
[5]Ling H,Spizzo R,Atlasi Y,et al.CCAT2,a novel noncoding RNA mapping to 8q24,underlies metastatic progression and chromosomal instability in colon cancer[J].Genome Research,2013,23(9):1446-1461.
[6]Shaker OG,Senousy MA,Elbaz EM.Association of rs6983267 at 8q24,HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients[J].Scientific Reports,2017,7(1):16246.
[7]Roxana S Redis,Luz E Vela,Lu W,et al.Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2[J].Molecular Cell,2016,61(4):520-534.
[8]Guo H,Hu G,Yang Q,et al.Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells[J].Oncotarget,2016,7(49):81806-81814.
[9]Peixoto RD,Speers C,Mcgahan CE,et al.Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer[J].Cancer Med,2015,4(8):1171-1177.
[10]Hopkins MH,Owen J,Ahearn T,et al.Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients:A randomized,controlled clinical trial[J].Cancer Prevention Research,2011,4(4):1645-1654.
[11]Yu Y,Nangiamakker P,Farhana L,et al.A novel mechanism of lncRNA and miRNA interaction:CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells[J].Molecular Cancer,2017,16(1):155.
[12]Li T,Zheng HM,Deng NM,et al.Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer[J].World J Gastroenterol,2017,23(8):1450-1457.
[13]Wu SW,Hao YP,Qui JH,et al.High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion[J].Minerva Medica,2017,108(4):317-323.
[14]Wang CY,Hua L,Yao KH,et al.Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis[J].Int J Clin Exp Pathol,2015,8(1):779-785.
[15]Wang YJ,Liu JZ,Lv P,et al.Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2[J].Am J Cancer Res,2016,6(11):2651-2660.
[16]Qian MB,Utzinger J,Keiser J.Clonorchiasis[J].Lancet(London,England),2016,387(10020):800-810.
[17]Bai JG,Tang RF,Shang JF,et al.Upregulation of long non coding RNA CCAT2 indicates a poor prognosis and promotes proliferation and metastasis in intrahepatic cholangiocarcinoma[J].Molecular Medicine Reports,2018,17(4):8328-8335.
[18]Xu Y,Yao Y,Qin W,et al.Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition[J].Biomedicine & Pharmacotherapy,2018,99:121-127.
[19]Frakes JM,Strom T,Springett GM,et al.Resected pancreatic cancer outcomes in the elderly[J].Journal of Geriatric Oncology,2015,6(2):127-132.
[20]Wang D,Chen Z,Xu H,et al.Long noncoding RNA CCAT2 as a novel biomaker of metastasis and prognosis in human cancer:A Meta-analysis[J].Oncotarget,2017,8(43):75664-75674.
[21]Cai Y,Li X,Shen P.CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma[J].Biological Research,2018,51(1):1.
[22]Zhu CP,Wang AQ,Zhang HH,et al.Research progress and prospects of markers for liver cancer stem cells[J].World Journal of Gastroenterology,2015,21(42):12190-12196.
[23]Zhou N,Si Z,Li T,et al.Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma,regulating cellular proliferation,migration and apoptosis[J].Oncology Letters,2016,12(1):132-138.
[24]Chen F,Bai G,Li Y,et al.A positive feedback loop of long noncoding RNA CCAT2 and FOXM1 promotes hepatocellular carcinoma growth[J].American Journal of Cancer Research,2017,7(7):1423-1434.
[25]Xu Y,Wang B,Zhang F,et al.Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition[J].Oncotargets & Therapy,2017,10:1191-1198.

Memo

Memo:
-
Last Update: 2018-12-29